Degree Programs

Dual MBA and MS in Biotechnology

Effective Fall 2024, the Heller Social Impact MBA is merging with the Brandeis International Business School MBA. Learn more.


Biotechnology is a rapidly growing sector of the United States and global economies. Its products are increasingly important in diagnosis, prevention, and treatment of disease. The Professional Master of Science Program in Biotechnology at Brandeis University (MS BIOT) equips students with skills to enter and advance in this dynamic industry. Graduates work in hospitals, biotechnology firms, bioscience research, and in the pharmaceutical industry. The Heller Social Impact MBA, with its specialization in Healthcare Management, primarily prepares students for work in organizations that manage healthcare delivery, research and policy (hospitals, insurance companies, biotech research and the like). The opportunity for MS BIOT students to acquire additional leading edge management skills via the Heller MBA, with its deep expertise in healthcare management, will optimally position them for significant leadership roles in a broad range of organizations in biotechnology and healthcare.

Program Description

This intensive program requires a minimum of 96 credit hours taken over six consecutive semesters.

Students in dual degree programs fulfill the complete requirements for each degree, earning degrees for both programs.


First Year



  • BIOL 100, Advanced Cell Biology (4 credits)

  • BIOL 251a, Project Lab in Protein Biochemistry (4)
  • BIOT 201, Business of Biotechnology (4 credits)

  • BIOT 203, Management for Biotechnology (4 credits)

  • Responsible Conduct of Research Workshop (non-credit)


  • BIOT Internship (12 credits)

Second Year

*Students may interchange these electives if desired (i.e., take a science elective when a management elective is indicated as long as 2 science electives and 1 management elective are taken during the program.